Breaking News

To stem overdoses, Canada is offering safer opioids; after early wins, CRISPR is about to get a lot harder

  

 

Daily Recap

'This program's really saved us': As Canada offers safer opioids to curb overdoses, will U.S. follow?

By Andrew Joseph

Laura Proctor for STAT

Canada's "safer supply" programs have critics. But U.S. advocates say that state-provided opioids can at least keep people alive.

Read More

STAT+: After early wins, CRISPR gene editing is about to get a lot harder

By Jason Mast

Adobe

CRISPR will need to hit more complicated parts of the body and will have to figure out how to repair genes, not just vandalize them.

Read More

Opinion: Termination is the safest course for some high-risk pregnancies. Dobbs decision threatens that care

By Jammie Law and Michael Pillinger and Julie Nusbaum

Eric Gay/AP

The Supreme Court has put abortion out of reach for many people, intimidates others into inaction, and jeopardizes maternal health.

Read More

STAT+: Researchers show they can quickly turn CAR-T cells on and off, raising hopes for safer cancer treatments

By Jonathan Wosen

Images courtesy Calibr

Researchers showed they could quell widespread inflammation often seen after CAR-T therapy within a couple days by switching the cells off.

Read More

Opinion: Listen: Polio is back in the U.S. Two physicians offer ways to fight its spread

By Patrick Skerrett

A case of polio in the U.S. has public health officials on high alert. Two physicians explain how it emerged and how to prevent its spread.

Read More

STAT+: Catalent is scolded by FDA for quality control issues at a plant that helps make Covid-19 vaccines

By Ed Silverman

Sarah Silbiger/Getty Images

The FDA issued a 19-page report on quality control issues after its inspectors spent the month of August at the Bloomington, Ind., facility.

Read More

Wednesday, September 21, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments